There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Bioxcel Therapeutics (BTAI), Madrigal Pharmaceuticals (MDGL) and CareDx (CDNA) with bullish sentiments.
Bioxcel Therapeutics (BTAI)
In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Bioxcel Therapeutics, with a price target of $95.00. The company’s shares closed last Tuesday at $25.02.
According to TipRanks.com, Selvaraju is a 1-star analyst with an average return of -1.4% and a 34.8% success rate. Selvaraju covers the Healthcare sector, focusing on stocks such as Taro Pharmaceutical Industries, Biospecifics Technologies, and Springworks Therapeutics.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Bioxcel Therapeutics with a $75.67 average price target.
See today’s analyst top recommended stocks >>
Madrigal Pharmaceuticals (MDGL)
In a report released today, Ed Arce from H.C. Wainwright maintained a Buy rating on Madrigal Pharmaceuticals, with a price target of $215.00. The company’s shares closed last Tuesday at $73.80.
According to TipRanks.com, Arce is a 5-star analyst with an average return of 7.7% and a 38.7% success rate. Arce covers the Healthcare sector, focusing on stocks such as Entasis Therapeutics Holdings, Collegium Pharmaceutical, and Aurinia Pharmaceuticals.
Currently, the analyst consensus on Madrigal Pharmaceuticals is a Strong Buy with an average price target of $180.40, a 134.3% upside from current levels. In a report released today, B.Riley FBR also reiterated a Buy rating on the stock with a $134.00 price target.
CareDx (CDNA)
H.C. Wainwright analyst Yi Chen reiterated a Buy rating on CareDx today and set a price target of $43.00. The company’s shares closed last Tuesday at $22.69.
According to TipRanks.com, Chen is a 5-star analyst with an average return of 10.6% and a 37.3% success rate. Chen covers the Healthcare sector, focusing on stocks such as HTG Molecular Diagnostics, EyePoint Pharmaceuticals, and Stealth Biotherapeutics.
CareDx has an analyst consensus of Moderate Buy, with a price target consensus of $53.00.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
